MolecuLight, a Toronto, Canada-based point-of-care fluorescence imaging firm, raised $11.7M in Sequence C funding.
The spherical was led by Export Growth Canada (EDC), Prosegur, and Azahar. Current traders additionally participated.
The corporate intends to make use of the funds to succeed in extra sufferers by offering clinicians with instruments to determine and quantify micro organism that impair wound therapeutic, in flip bettering affected person outcomes.
Led by CEO Anil Amlani, MolecuLight is a point-of-care fluorescence imaging firm whose gadgets empower healthcare suppliers to detect elevated ranges of micro organism in wounds, surgical websites, and different accidents. By optimizing remedy plans, the expertise helps customers speed up therapeutic and cut back the danger of issues. The multi-modal system combines bacterial detection, wound measurement, and imaging capabilities right into a single instrument, streamlining workflows and bettering documentation accuracy. Integrating with digital medical information, MolecuLight empowers clinicians to ship the very best commonplace of care whereas optimizing their workflow.
FinSMEs
15/08/2024
